H.C. Wainwright Upgrades Intercept Pharmaceuticals (ICPT) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ACCV
2. IIB:IN
3. AZN
4. SMMT
5. GMAB
6. IVBIY
7. SPY
8. BMY
9. TSLA
10. JNJ

Go back to H.C. Wainwright Upgrades Intercept Pharmaceuticals (ICPT) to Neutral

Intercept Pharma (ICPT) Announces Departure of Chief Financial Officer

March 10, 2021 8:05 AM EST

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Sandip Kapadia, Chief Financial Officer, will leave Intercept to pursue another opportunity. Mr. Kapadia will continue to serve as Chief Financial Officer until his departure on March 26, 2021. The Company also announced Mr. Rocco Venezia will be... More